The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers
Open accessAbstract
BACKGROUND: Staphylococcus aureus (S. aureus) is the leading nosocomial (hospital acquired) pathogen in hospitals throughout the world. Traditionally, control of S. aureus has been focused on preventing cross-infection between patients, however, it has been shown repeatedly that a large proportion of nosocomial S. aureus infections originate from the patient's own flora. Nasal carriage of S. aureus is now considered a well defined risk factor for subsequent infection in various groups of patients. Local antibiotic treatment with mupirocin ointment is often used to eradicate nasal S. aureus. OBJECTIVES: To determine whether the use of mupirocin nasal ointment in patients with identified S. aureus nasal carriage reduced S. aureus infection rates. SEARCH STRATEGY: We searched the Cochrane Wounds Group Specialised Register (May 2008), the Cochrane Central Register of Controlled Trials (CENTRAL, Issue 2 2008), MEDLINE (1950 to May 2008), EMBASE (1980 to May 2008) and CINAHL (1982 to May 2008). To identify unpublished trials, abstract books from major scientific meetings (ICAAC, ESCMID and SHEA) were handsearched, researchers and manufacturers of mupirocin were contacted and other electronic databases were searched (SIGLE, ASLIB Index, mRCT, USA Clinical Trials). SELECTION CRITERIA: Randomised controlled trials (RCTs) comparing nasal mupirocin with no treatment or placebo or alternative nasal treatment in the prevention of S. aureus infections in nasal S. aureus carriers were included. DATA COLLECTION AND ANALYSIS: Titles, abstracts and full-text articles of studies retrieved from the search process were independently assessed by two authors for inclusion. From included studies a data extraction form was made and the quality of the trial was assessed. The primary outcome was the S. aureus infection rate (any site). Secondary outcomes were time to infection, mortality, adverse events and infection rate caused by micro-organisms other than S. aureus. MAIN RESULTS: Nine RCTs involving 3396 participants met the inclusion criteria. Patient populations varied and several types of nosocomial S. aureus infection were described including bacteraemia, exit-site infections, peritonitis, respiratory tract infections, skin infections, surgical site infections (SSI) and urinary tract infections. After pooling the eight studies that compared mupirocin with placebo or with no treatment, there was a statistically significant reduction in the rate of S. aureus infection associated with intranasal mupirocin (RR 0.55, 95% CI 0.43 to 0.70).A planned subgroup analysis of surgical trials demonstrated a significant reduction in the rate of nosocomial S. aureus infection rate associated with mupirocin use (RR 0.55, 95% CI 0.34 to 0.89) however this effect disappeared if the analysis only included surgical site infections caused by S. aureus (RR 0.63, 95% CI 0.38 to 1.04), possibly due to a lack of power. The infection rate caused by micro-organisms other than S. aureus was significantly higher in patients treated with mupirocin compared with control patients (RR 1.38 95% CI 1.118 to 1.72). AUTHORS' CONCLUSIONS: In people who are nasal carriers of S. aureus, the use of mupirocin ointment results in a statistically significant reduction in S. aureus infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Guideline for Prevention of Surgical Site Infection, 1999
Mangram, A. J., Horan, T. C., Pearson, M. L., Silver, L. C., Jarvis, W. R., & The Hospital Infection Control Practices Advisory Committee (1999) · Infection Control & Hospital Epidemiology · doi:10.1086/501620 · Cited by 4,595
Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks
Kluytmans, J., van Belkum, A., & Verbrugh, H. (1997) · Clinical Microbiology Reviews · doi:10.1128/cmr.10.3.505 · Cited by 2,595
Self-citationEffectiveness of a hospital-wide programme to improve compliance with hand hygiene
Pittet, D., Hugonnet, S., Harbarth, S., Mourouga, P., Sauvan, V., Touveneau, S., & Perneger, T. V. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02814-2 · Cited by 2,524
System, A. R. F. T. N. (2004) · American Journal of Infection Control · doi:10.1016/j.ajic.2004.10.001 · Cited by 2,342
Nasal Carriage as a Source of Staphylococcus aureus Bacteremia
von Eiff, C., Becker, K., Machka, K., Stammer, H., & Peters, G. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101043440102 · Cited by 1,984
Preventing Surgical-Site Infections in Nasal Carriers of Staphylococcus aureus
Bode, L. G. M., Kluytmans, J. A. J. W., Wertheim, H. F. L., Bogaers, D., Vandenbroucke-Grauls, C. M. J. E., Roosendaal, R., Troelstra, A., Box, A. T. A., Voss, A., van der Tweel, I., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0808939 · Cited by 1,219
Self-citationWertheim, H. F., Vos, M. C., Ott, A., van Belkum, A., Voss, A., Kluytmans, J. A., van Keulen, P. H., Vandenbroucke-Grauls, C. M., Meester, M. H., & Verbrugh, H. A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16897-9 · Cited by 892
Self-citationIntranasal Mupirocin to Prevent Postoperative Staphylococcus aureus Infections
Perl, T. M., Cullen, J. J., Wenzel, R. P., Zimmerman, M. B., Pfaller, M. A., Sheppard, D., Twombley, J., French, P. P., & Herwaldt, L. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa003069 · Cited by 799
Self-citationLefebvre, C., Manheimer, E., & Glanville, J. (2008) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9780470712184.ch6 · Cited by 559
Staphylococcus aureus Nasal Carriage and Infection in Patients on Hemodialysis
Yu, V. L., Goetz, A., Wagener, M., Smith, P. B., Rihs, J. D., Hanchett, J., & Zuravleff, J. J. (1986) · New England Journal of Medicine · doi:10.1056/nejm198607103150204 · Cited by 475
(2004) · PubMed · doi:10.1016/s0196655304005425 · Cited by 465
Kluytmans, J. A. J. W., Mouton, J. W., Ijzerman, E. P. F., Vandenbroucke-Grauls, C. M. J. E., Maat, A. W. P. M., Wagenvoort, J. H. T., & Verbrugh, H. A. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.1.216 · Cited by 436
Self-citationKalmeijer, M. D., Coertjens, H., van Nieuwland‐Bollen, P. M., Bogaers‐Hofman, D., de Baere, G. A. J., Stuurman, A., van Belkum, A., & Kluytmans, J. A. J. W. (2002) · Clinical Infectious Diseases · doi:10.1086/341025 · Cited by 348
Self-citationNoskin, G. A., Rubin, R. J., Schentag, J. J., Kluytmans, J., Hedblom, E. C., Smulders, M., Lapetina, E., & Gemmen, E. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.15.1756 · Cited by 299
Self-citationFrancois, P., Pittet, D., Bento, M., Pepey, B., Vaudaux, P., Lew, D., & Schrenzel, J. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.1.254-260.2003 · Cited by 294
Simor, A. E., Phillips, E., McGeer, A., Konvalinka, A., Loeb, M., Devlin, H. R., & Kiss, A. (2007) · Clinical Infectious Diseases · doi:10.1086/510392 · Cited by 286
Harbarth, S., Dharan, S., Liassine, N., Herrault, P., Auckenthaler, R., & Pittet, D. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1412 · Cited by 286
van Rijen, M. M. L., Bonten, M., Wenzel, R. P., & Kluytmans, J. A. J. W. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm480 · Cited by 207
Self-citationLaupland, K. B., & Conly, J. M. (2003) · Clinical Infectious Diseases · doi:10.1086/377735 · Cited by 169
Mody, L., Kauffman, C. A., McNeil, S. A., Galecki, A. T., & Bradley, S. F. (2003) · Clinical Infectious Diseases · doi:10.1086/379325 · Cited by 167
Impact of treating Staphylococcus aureus nasal carriers on wound infections in cardiac surgery
Konvalinka, A., Errett, L. E., & Fong, I. W. (2006) · Journal of Hospital Infection · doi:10.1016/j.jhin.2006.06.010 · Cited by 152
Wertheim, H. F. L., Vos, M. D., Ott, A., Voß, A., Kluytmans, J. A. J. W., Vandenbroucke‐Grauls, C. M. J. E., Meester, M. H. M., van Keulen, P. H. J., & Verbrugh, H. A. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-6-200403160-00007 · Cited by 146
Self-citationBoelaert, J. R., Smedt, R. A. D., Baere, Y. A. D., Godard, C. A., Matthys, E. G. J., Schurgers, M., Daneels, R. F., Gordts, B., & Landuyt, H. W. V. (1989) · Nephrology Dialysis Transplantation · doi:10.1093/oxfordjournals.ndt.a091872 · Cited by 143
Hudson, I. (1994) · Journal of Hospital Infection · doi:10.1016/0195-6701(94)90001-9 · Cited by 139
Raz, R. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00040041109010 · Cited by 113
Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients
Campbell, D. J., Mudge, D. W., Craig, J. C., Johnson, D. W., Tong, A., & Strippoli, G. F. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004679.pub3 · Cited by 107
Paule, S. M., Pasquariello, A. C., Hacek, D. M., Fisher, A. G., Thomson, R. B., Kaul, K. L., & Peterson, L. R. (2004) · Journal of Molecular Diagnostics · doi:10.1016/s1525-1578(10)60509-0 · Cited by 90
Kaplowitz, L. G., Comstock, J. A., Landwehr, D. M., Dalton, H. P., & Mayhall, C. G. (1988) · Journal of Clinical Microbiology · doi:10.1128/jcm.26.7.1257-1262.1988 · Cited by 81
Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients
Strippoli, G. F., Tong, A., Johnson, D. W., Schena, F. P., & Craig, J. C. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004679.pub2 · Cited by 81
Yzerman, E. P. F., Boelens, H. A. M., Tjhie, J. H. T., Kluytmans, J. A. J. W., Mouton, J. W., & Verbrugh, H. A. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/173.4.914 · Cited by 63
Self-citationMartin, J. N., Perdreau‐Remington, F., Kartalija, M., Pasi, O. G., Webb, M., Gerberding, J. L., Chambers, H. F. “., Täuber, M. G., & Lee, B. L. (1999) · The Journal of Infectious Diseases · doi:10.1086/314949 · Cited by 53
Treatment of Staphylococcus aureus nasal carriers in CAPD with mupirocin.
Fontán, M. P., Rosales, M., Rodríguez–Carmona, A., Moncalián, J., Fernández-Rivera, C., Cao, M., & Valdés, F. (1992) · PubMed · Cited by 50
Leigh, D. A., & Joy, G. (1993) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/31.6.909 · Cited by 33
Eradication of MRSA nasal colonization as a strategy for infection prevention
Critchley, I. A. (2006) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2006.05.003 · Cited by 7
Cited by
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq146 · Cited by 4,191
Clinical practice guidelines for antimicrobial prophylaxis in surgery
Bratzler, D. W., Dellinger, E. P., Olsen, K. M., Perl, T. M., Auwaerter, P. G., Bolon, M. K., Fish, D. N., Napolitano, L. M., Sawyer, R. G., Slain, D., et al. (2013) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp120568 · Cited by 2,591
Antibacterial free fatty acids: activities, mechanisms of action and biotechnological potential
Desbois, A. P., & Smith, V. J. (2010) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-009-2355-3 · Cited by 1,442
Preventing Surgical-Site Infections in Nasal Carriers of Staphylococcus aureus
Bode, L. G. M., Kluytmans, J. A. J. W., Wertheim, H. F. L., Bogaers, D., Vandenbroucke-Grauls, C. M. J. E., Roosendaal, R., Troelstra, A., Box, A. T. A., Voss, A., van der Tweel, I., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0808939 · Cited by 1,219
Self-citationStrategies to Prevent Surgical Site Infections in Acute Care Hospitals: 2014 Update
Anderson, D. J., Podgorny, K., Berríos-Torres, S. I., Bratzler, D. W., Dellinger, E. P., Greene, L., Nyquist, A.-C., Saiman, L., Yokoe, D. S., Maragakis, L. L., et al. (2014) · Infection Control & Hospital Epidemiology · doi:10.1086/676022 · Cited by 1,216
Metadata
- Authors
- van Rijen, M., Bonten, M., Wenzel, R., & Kluytmans, J.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2008-10-08
- Volume
- 2011
- Issue
- 2
- Pages
- CD006216-CD006216
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2127879007
- Cited by
- 286
- References
- 36
- FWCI
- 13.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.